Cell-Free Hormone Synthesis via Lyophilized SUMO Fusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for manufacturing and distributing protein hormones, such as those for treating diabetes, obesity, and osteoporosis, face challenges due to centralized manufacturing and the need for cold-chain distribution, making access difficult in resource-limited settings.
Innovation Solution
A cell-free protein synthesis platform that enables point-of-care production and on-site purification of therapeutic hormones using lyophilized cell-free expression and purification systems, allowing for room temperature storage and transportation, and on-demand synthesis with a SUMO fusion tag for stabilization and purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If centralized manufacturing and cold-chain distribution are used for protein hormones, then manufacturing precision and product stability are improved, but accessibility and distribution cost worsen in resource-limited settings
Solution Approach 1:
The patent extracts the essential protein synthesis machinery from living cells to create a cell-free system. This allows the hormone production process to be decoupled from biological constraints requiring cold-chain storage, enabling the system to function at room temperature while maintaining protein production quality and accessibility in resource-limited settings
Solution Approach 2:
The patent changes the operational parameters of protein synthesis from cell-based (requiring controlled temperature, pH, and nutrient supply) to cell-free chemical reactions. This parameter transformation allows the system to operate stably at room temperature without cold-chain infrastructure, improving accessibility while maintaining manufacturing precision through optimized reaction conditions
2Ease of operation
If cell-free protein synthesis is used for point-of-care production, then accessibility and ease of manufacture are improved, but system complexity and purification requirements worsen
Solution Approach 1:
The patent incorporates purification elements directly into the cell-free expression system setup. By pre-incorporating affinity tags or using chromatography-resin combinations in the reaction mixture, the system performs purification actions automatically during or after the synthesis process, eliminating the need for separate complex purification equipment while maintaining ease of operation
Solution Approach 2:
The patent designs the cell-free system to perform multiple functions: protein synthesis, stabilization via fusion tags, and purification through integrated chromatography elements. This multi-functionality reduces overall system complexity by combining what would traditionally require separate systems into a single point-of-care platform
3Stability of the object's composition
If lyophilized cell-free expression systems are used for room temperature storage, then storage stability and distribution ease are improved, but manufacturing cost and system complexity worsen
Solution Approach 1:
The patent utilizes lyophilization (freeze-drying) to transform the cell-free expression system from a liquid state requiring cold-chain storage to a solid, stable powder form that can be stored at room temperature. This phase transition enables long-term stability and ease of distribution while the cost is offset by the elimination of cold-chain infrastructure requirements
Solution Approach 2:
The patent incorporates stabilization elements such as fusion tags and protective additives into the cell-free system during the lyophilization process. These preliminary actions ensure the system remains stable and functional after reconstitution from lyophilized form, reducing the need for expensive cold-chain storage while maintaining system effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a stable, low-cost method for producing therapeutic hormones that can be synthesized and purified on-site, eliminating the need for cold-chain storage and expanding access to resource-limited settings, while ensuring the hormones are identical to endogenous forms.
Implementation Method 1
cell-free protein synthesis reaction to produce therapeutic peptides
Implementation Method 2
SUMO fusion tag for stabilization and purification
Implementation Method 3
lyophilized cell-free expression and purification systems, allowing for room temperature storage
Data Source
AI summary
The present disclosure relates to stable, cost-effective, cell-free systems, compositions, methods, and kits for bio-manufacturing and purifying therapeutic hormones. The systems, methods, and kits allow for cell-free bio-manufacturing of the desired hormone products in cell-free conditions, wherein the system can be stably stored or transported, in lyophilized form.